A Study to Investigate the Effects and Safety of SPG601 for the Treatment of Fragile X Syndrome in Male Participants

Clinical trial NCT07439510 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07439510
Sponsor: Spinogenix
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Fragile X Syndrome (FXS)

Start date: 2026-03-01
Primary completion: 2030-02-01
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.